Angel Qin, MD, identified the critical role of immunotherapy timing and shared decision-making in small cell lung cancer while also addressing the need for more broadly applicable treatments and personalized care.
Angel Qin, MD
Advertisement
thoracic medical oncologist and associate professor at the University of Michigan
Articles by Angel Qin, MD
Recent clinical trials like ADRIATIC and IMforte are shaping the future of small cell lung cancer (SCLC) treatment, explained Angel Qin, MD. She also emphasized the growing role of immunotherapy in adjuvant and maintenance therapies.
Advertisement
Latest Updated Articles
Addressing Unmet Needs in Lung Cancer to Optimize Precision Medicine and Immunotherapy: Angel Qin, MDPublished: August 8th 2025 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
Boosting RSV Vaccination in Older Adults Could Save Thousands
3
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
4
Real-World Data Key to Optimizing CAR T-Cell Therapy Delivery, Outcomes
5
